Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center, discusses how diversity in clinical trials are helping bridge the racial health equity gap in psoriasis care.
Researchers and clinicians must effectively translate findings from diverse clinical trials into practice through medical journals, conferences, and continuous education to bridge gaps in health equity, says
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
This transcript was lightly edited.
Transcript
How can researchers and clinicians ensure that the findings from clinical trials involving diverse populations are accurately represented and effectively translated into the clinical practice?
What’s great is that's the natural flow of knowledge. Our knowledge naturally comes from clinical trials into when we see the patient. Meaning, we have a clinical trial, those results go into the medical journal. The medical journals are what we use to write our medical textbooks. Medical textbooks is how we teach our medical students, who then become physicians that treat patients. That's just a natural flow. So, the importance is that the clinical trials are diverse, and that's that long game of closing the gap of the race-health-equity gap that we have. This is actually how we operate. It almost always starts with a clinical trial.
As we know from clinical trials, there's always spin offs. So, when I see something quite interesting, that might give me an idea to then do a little mini study with my patients. Saying, "I'm going to see if this medication does indeed work better for scalp psoriasis [which is] more common in Blacks," and then we go from there. But for it to be accurately represented is typical.
For those of us that are already in practices, and we're not in medical school, we read our journals, but conferences are where we go to learn. It's a one-stop shop. So, in private practice, we don't quite have the same time allotted to education. To take time away from seeing patients and go to a conference, that's where we learn up to date information and then apply it into our clinical practice.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer
October 31st 2024Novel evidence has emerged from a 16-year study that hidradenitis suppurativa can elevate risks of not only pregnancy and postpartum complications, but of morbidity—particularly metabolic- and immunology-related morbidity—for mother and child in the long term.
Read More